Evidence map›Paper›PMID 28794144›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2017

Nasal high flow therapy: a novel treatment rather than a more expensive oxygen device.

Eleni Ischaki, Ioannis Pantazopoulos, Spyros Zakynthinos

4 registry-linked trialsOpen access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 39 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 3 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03466385 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Nasal High Flow Versus Non-Invasive Ventilation in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

TypeinterventionalSponsorEvangelismos HospitalRan2018 to 2021Enrolled498ConditionsChronic Obstructive Pulmonary Disease, Respiratory Failure, Acute Exacerbation CopdArmsNasal High Flow, Non-Invasive Ventilation
NCT03515031 naunknown statusnot on this mapstarted 2023, after this paper: background citation

Open Randomized Controlled Clinical Trial Comparing Oxygen Therapy by High Flow Nasal Cannulae and by Venturi Mask in the Treatment of Acute Respiratory Failure Due to Severe Pneumonia (Hi Flow Oxygen vs Venturi Mask In Pneumonia)

TypeinterventionalSponsorPapa Giovanni XXIII HospitalRan2023 to 2026Enrolled150ConditionsRespiratory Insufficiency, PneumoniaArmsHigh Flow Nasal Cannula Oxygenation, Venturi Mask Oxygenation
NCT05829083 narecruitingnot on this mapstarted 2023, after this paper: background citation

Asymmetric (DUET) Versus Conventional Nasal High Flow Interface for Management of Hypercapnic Patients With Mild to Moderate Acute Exacerbation of COPD: A Randomized, Crossover Clinical Trial

TypeinterventionalSponsorLarissa University HospitalRan2023 to 2025Enrolled50ConditionsCOPD Exacerbation, Hypercapnia, COPDArmsAsymmetric nasal cannula - DUET, Conventional nasal high flow cannula
NCT07059728 narecruitingnot on this mapstarted 2025, after this paper: background citation

Uso de Lentillas de Alto Flujo en Procedimientos de sustitución de válvula aórtica transcatéter. Impacto en Las Complicaciones Respiratorias y Biomarcado- Res y Resultados clínicos. TAVR-Highflow

TypeinterventionalSponsorHospital Clinic of BarcelonaRan2025 to 2027Enrolled452ConditionsAortic Stenosis Treated With TAVI, Sedation, Aged, HemodynamicsArmsOxygen therapy during sedation provided via high nasal cannulae (60L/min at 60% FiO2), Oxygen therapy during sedation delivered via nasal cannulae at 5L/min
3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 3 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Effect of noninvasive respiratory support on interstitial lung disease with acute respiratory failure: A systematic review and meta-analysis.Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR · 2023
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Eleni IschakiFirst Dept of Critical Care Medicine and Pulmonary Services, Medical School of National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece eischaki@yahoo.gr.
Ioannis PantazopoulosFirst Dept of Critical Care Medicine and Pulmonary Services, Medical School of National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece.
Spyros ZakynthinosFirst Dept of Critical Care Medicine and Pulmonary Services, Medical School of National and Kapodistrian University of Athens, Evangelismos Hospital, Athens, Greece.
Evangelismos Hospital · GRNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nasal high flow is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. The administration of a high flow of heated and humidified gas mixture promotes higher and more stable inspiratory oxygen fraction values, decreases anatomical dead space and generates a positive airway pressure that can reduce the work of breathing and enhance patient comfort and tolerance. Nasal high flow has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxaemic respiratory failure, with the majority of studies showing positive results. Recently, its clinical indications have been expanded to post-extubated patients in intensive care or following surgery, for pre- and peri-oxygenation during intubation, during bronchoscopy, in immunocompromised patients and in patients with "do not intubate" status. In the present review, we differentiate studies that suggest an advantage (benefit) from other studies that do not suggest an advantage (no benefit) compared to conventional oxygen devices or noninvasive ventilation, and propose an algorithm in cases of nasal high flow application in patients with acute hypoxaemic respiratory failure of almost any cause.

Indexed as

Administration, IntranasalAlgorithmsCritical PathwaysDecision Support TechniquesEquipment DesignHealth Care CostsHumansHypoxiaLungNoninvasive VentilationOxygen Inhalation TherapyRespiratory InsufficiencyTreatment Outcome

Identifiers

PMID28794144
PMCPMC9488954
OpenAlexW2744879880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.